11. THU0299 B Cell Compartment and Pharmacodynamics of Belimumab in Systemic Lupus Erythematosus: Early Clinical Efficacy by Depletion of CD27- and Increase of CD27+ B Cells. (15th July 2016) Authors: Quartuccio, L.; De Marchi, G.; Rossi, F.M.; Zuliani, F.; Bond, M.; Picco, L.; Masolini, P.; Rizzolio, F.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. THU0402 Increased Expression of Baff Receptor on B Cells May be Implicated in Delayed Response in Systemic Lupus Erythematosus Patients Under Belimumab Therapy. (9th June 2015) Authors: Quartuccio, L.; De Marchi, G.; Rossi, F.; Zuliani, F.; Corazza, L.; Picco, L.; Masolini, P.; Rizzolio, F.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗